Profil bibliographique

Annemiek de Ruiter

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

89Publications signalées

4869Citations signalées

2Affiliations récentes

Institutions déclarées

ViiV Healthcare (Spain)ViiV Healthcare (United Kingdom)

Domaines associés

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and TreatmentHIV-related health complications and treatmentsHIV, Drug Use, Sexual Risk

Publications récentes

Accès ouvert 2026 article

HIV Preexposure Prophylaxis Utilization and Reasons for Never Using Preexposure Prophylaxis Among Transfeminine Persons in the United States: Findings From the Transgender Women’s Internet Survey and Testing (TWIST) Study

Duygu Islek, Travis Sanchez, Stefan Baral, Joanna A. Caldwell et autres

1 citationOpen Forum Infectious Diseases

Accès ouvert 2026 article

P-345. Prevalence of Integrase HIV-1 Drug Resistance Mutations in the United States: 2019-2024

Cassidy Henegar, Johnny Lai, Kimberley Brown, Bryn Jones et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2026 article

Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort

Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Philip C Lackey et autres

0 citationsJournal of the International Association of Providers of AIDS Care (JIAPAC)

2025 article

Characteristics Associated With the HIV Preexposure Prophylaxis Care Continuum Among Transfeminine Persons in the United States

Duygu İşlek, Travis Sanchez, Stefan Baral, Joanna A. Caldwell et autres

0 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes

Accès ouvert 2025 article

Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study

Katherine Nelson, Yolanda Lawson, Dylan Baker, Satish Mocherla et autres

5 citationsJournal of the International AIDS Society

Accès ouvert 2025 article

Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022–2023

Duygu İşlek, Travis Sanchez, Stefan Baral, Carolyn Brown et autres

3 citationsPLoS ONE

Accès ouvert 2025 article

P-1899. Improvement in Provider Experiences from Baseline to Month 12 with Integrating Cabotegravir Long-Acting (CAB LA) for PrEP into Care in an Implementation Science Trial (PILLAR)

Taimur Khan, Jonathan M. L. White, Leida Mercado, Bo Li et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2024 review

Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review

William R. Short, Parul Patel, Gustavo Verdier, Ana M. Puga et autres

5 citationsInfectious Diseases and Therapy

Accès ouvert 2024 article

Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study

Erin E. Cooney, Megan Stevenson, Rodrigo A. Aguayo‐Romero, G. Guerra Valera et autres

1 citationAIDS and Behavior

Accès ouvert 2024 article

Efficacy and Safety of DTG/3TC for Prophylaxis of HIV Perinatal Transmission: A Pilot Study (PREGNANCY)

Carlos Brites, Estela Luz, Isabella Nóbrega, Ivana Luz et autres

2 citationsOpen Forum Infectious Diseases

Accès ouvert 2024 article

Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States

Erin E. Cooney, Sari L. Reisner, Tonia Poteat, Keri N. Althoff et autres

6 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes

Accès ouvert 2024 article

Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV

Vani Vannappagari, Scott McCallister, Beth Romach, Mark Bush et autres

4 citationsInfectious Diseases and Therapy

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.